Literature DB >> 11886257

Human immunodeficiency virus type 1 preferentially encapsidates genomic RNAs that encode Pr55(Gag): functional linkage between translation and RNA packaging.

Dexter T K Poon1, Elena N Chertova, David E Ott.   

Abstract

Full-length retroviral RNA serves as both messenger and genomic RNA. Therefore, an unspliced RNA could play both roles: viral mRNA could be bound in cis by the same Gag polyprotein that it produced, becoming a packaged genomic RNA. To test this possibility, we used in vivo packaging experiments which coexpressed wild-type NL4-3 RNA and NL4-3-based mutant RNA that, ideally, could not translate Gag. However, mutating the gag initiator produced a mutant (pNLX) that expressed a truncated Gag, Gag*, initiated at methionine 10 in the CA region (142 of Pr55(Gag)). Gag* can be rescued into virions by Gag and, as it contains the NC domain, could package RNA in cis. To eliminate NC and the CA dimerization domain, a nonsense mutation in CA at residue 99 was introduced into pNLX to produce pNLXX, which expresses an RNA that should only be packaged in trans. Cotransfection packaging experiments revealed that wild-type genomic RNA was packaged at an 8-fold greater level than NLXX RNA given equal expression of both RNAs. Experiments that varied the relative amounts of these RNAs in the cell found that the wild-type RNA was encapsidated with a packaging preference (i.e., the relative amount of this RNA in virions versus cells) of 6- to 13-fold over the NLXX RNA, showing that the NLXX RNA did not efficiently compete with NL4-3 RNA. These data suggest that the wild-type RNA's ability to express Pr55(Gag) and, by inference, actively translate Gag confers an advantage in packaging over the nearly identical NLXX RNA. In contrast, the NLX RNA competed with wild-type RNA at a 1-to-3 preference. This ratio is similar to the amounts of Gag* rescued by Gag, suggesting that the presence of Gag* assists in the encapsidation of NLX RNA. Together, our data link translation and particle formation to the packaging of viral RNA and support a model of cis packaging where nascent Gag proteins encapsidate their cognate RNA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11886257     DOI: 10.1006/viro.2001.1283

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  36 in total

1.  A structural linkage between the dimerization and encapsidation signals in HIV-2 leader RNA.

Authors:  Jean-Marc Lanchy; John D Ivanovitch; J Stephen Lodmell
Journal:  RNA       Date:  2003-08       Impact factor: 4.942

2.  The 5' untranslated region and Gag product of Idefix, a long terminal repeat-retrotransposon from Drosophila melanogaster, act together to initiate a switch between translated and untranslated states of the genomic mRNA.

Authors:  Carine Meignin; Jean-Luc Bailly; Frédérick Arnaud; Bernard Dastugue; Chantal Vaury
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 3.  Properties and functions of the nucleocapsid protein in virus assembly.

Authors:  Delphine Muriaux; Jean-Luc Darlix
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 4.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

5.  Unexpected roles for UPF1 in HIV-1 RNA metabolism and translation.

Authors:  Lara Ajamian; Levon Abrahamyan; Miroslav Milev; Pavel V Ivanov; Andreas E Kulozik; Niels H Gehring; Andrew J Mouland
Journal:  RNA       Date:  2008-03-27       Impact factor: 4.942

Review 6.  Diverse interactions of retroviral Gag proteins with RNAs.

Authors:  Alan Rein; Siddhartha A K Datta; Christopher P Jones; Karin Musier-Forsyth
Journal:  Trends Biochem Sci       Date:  2011-05-06       Impact factor: 13.807

7.  Effects of mutations in the human immunodeficiency virus type 1 Gag gene on RNA packaging and recombination.

Authors:  Olga Nikolaitchik; Terence D Rhodes; David Ott; Wei-Shau Hu
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

8.  Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly.

Authors:  David E Ott; Lori V Coren; Tracy D Gagliardi
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

9.  Identifying the assembly intermediate in which Gag first associates with unspliced HIV-1 RNA suggests a novel model for HIV-1 RNA packaging.

Authors:  Brook C Barajas; Motoko Tanaka; Bridget A Robinson; Daryl J Phuong; Kasana Chutiraka; Jonathan C Reed; Jaisri R Lingappa
Journal:  PLoS Pathog       Date:  2018-04-17       Impact factor: 6.823

10.  Visualizing the translation and packaging of HIV-1 full-length RNA.

Authors:  Jianbo Chen; Yang Liu; Bin Wu; Olga A Nikolaitchik; Preeti R Mohan; Jiji Chen; Vinay K Pathak; Wei-Shau Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.